"Anticonvulsants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent SEIZURES or reduce their severity.
| Descriptor ID |
D000927
|
| MeSH Number(s) |
D27.505.954.427.080
|
| Concept/Terms |
Anticonvulsants- Anticonvulsants
- Anticonvulsive Agents
- Agents, Anticonvulsive
- Anticonvulsive Drugs
- Drugs, Anticonvulsive
- Anticonvulsant Drugs
- Drugs, Anticonvulsant
Antiepileptic Agents- Antiepileptic Agents
- Agents, Antiepileptic
- Antiepileptics
- Antiepileptic Drugs
- Drugs, Antiepileptic
|
Below are MeSH descriptors whose meaning is more general than "Anticonvulsants".
Below are MeSH descriptors whose meaning is more specific than "Anticonvulsants".
This graph shows the total number of publications written about "Anticonvulsants" by people in this website by year, and whether "Anticonvulsants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 2 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 4 | 3 | 7 |
| 2005 | 3 | 0 | 3 |
| 2006 | 0 | 4 | 4 |
| 2007 | 2 | 3 | 5 |
| 2008 | 4 | 2 | 6 |
| 2009 | 3 | 1 | 4 |
| 2010 | 6 | 0 | 6 |
| 2011 | 3 | 2 | 5 |
| 2012 | 1 | 3 | 4 |
| 2013 | 0 | 1 | 1 |
| 2014 | 4 | 2 | 6 |
| 2015 | 4 | 1 | 5 |
| 2016 | 4 | 2 | 6 |
| 2017 | 3 | 2 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 3 | 3 | 6 |
| 2021 | 1 | 2 | 3 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 3 | 4 |
| 2024 | 1 | 1 | 2 |
| 2025 | 4 | 0 | 4 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticonvulsants" by people in Profiles.
-
Acute and Long-Term EEG and seizure characteristics in new onset refractory status epilepticus (NORSE). Epilepsia. 2026 Sep; 67(9):4857-4869.
-
Seizure Burden and Management in Infants With Hemimegalencephaly Prestaged and Poststaged Transarterial Embolization. Pediatr Neurol. 2026 Aug; 181:31-37.
-
Retrospective observational study of treatment and referral pathways of patients with epilepsy in Germany. Seizure. 2026 May; 138:157-166.
-
Prophylactic Antiseizure Medication in Patients with Lobar Intracerebral Hemorrhage. Neurocrit Care. 2026 Jun; 44(3):850-856.
-
Efficacy and tolerability of fenfluramine with concomitant potassium bromide in patients with Dravet syndrome. Epilepsia Open. 2025 Oct; 10(5):1323-1333.
-
Comparative effectiveness of second-line treatments for epileptic spasms. Epilepsia. 2025 Oct; 66(10):3799-3809.
-
Real-world experience of cannabidiol in conjunction with clobazam for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome: Results from a retrospective multicentre chart review in Germany. Epilepsy Behav. 2025 05; 166:110302.
-
Initial Management of Acute Seizures and Status Epilepticus. Med Clin North Am. 2025 Mar; 109(2):497-508.
-
Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
-
Editors' Note: Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study. Neurology. 2023 08 08; 101(6):282.